SCHEMBL171246

SCHEMBL171246

CNC(=O)c1cc(Oc2ccc(CNC(=O)Nc3cc(Cl)ccc3Cl)cc2C)ccn1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDR2 Q16832 5/20 0.86
RAB9A P51151 1/20 0.45
RAF1 P04049 5/20 0.44
KDR P35968 4/20 0.44
BRAF P15056 3/20 0.44
RET P07949 3/20 0.44
MAPK14 Q16539 3/20 0.44
RIPK2 O43353 2/20 0.44
ABCB11 O95342 2/20 0.44
ABL1 P00519 2/20 0.44
HTR1A P08908 2/20 0.44
PDGFRB P09619 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
KIT P10721 2/20 0.44
FGFR1 P11362 2/20 0.44
PDGFRA P16234 2/20 0.44
FLT1 P17948 2/20 0.44
MAOA P21397 2/20 0.44
EPHA1 P21709 2/20 0.44
TBXA2R P21731 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13603518 0.92 DDR2 (1.00) DDR2RAF1MEN1CSF1RKMT2A
SCHEMBL15574582 0.87 DDR2 (0.81) DDR2RAF1KDRMAPK14CSF1R
SCHEMBL15573125 0.86 DDR2 (0.72) DDR2RAF1KDRBRAFRET
SCHEMBL171212 0.86 DDR2 (0.83) DDR2RAF1KDRBRAFRET
SCHEMBL171397 0.86 DDR2 (0.83) DDR2RAF1KDRBRAFRET
SCHEMBL15573230 0.85 DDR2 (0.73) DDR2RAF1KDRBRAFRET
SCHEMBL171280 0.85 DDR2 (0.71) DDR2RAF1KDRBRAFRET
SCHEMBL17000078 0.84 DDR2 (0.82) DDR2RAF1KDRMAPK14EPHX2
SCHEMBL169152 0.84 DDR2 (0.62) DDR2RAB9ARAF1KDRBRAF
SCHEMBL15574740 0.84 DDR2 (0.71) DDR2RAF1KDRBRAFRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158076-A1 Methylene Urea Derivatives MERCK PATENT GMBH (DE) 2013-06-20 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
EP-2426122-A1 Methylene urea derivative as RAF kinasse inhibitors Merck Patent GmbH (DE) 2012-03-07 EP disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298885-A1 METHYLENE UREA DERIVATIVES BRAF, RAF1, CMPK1 DDR2 4558/4885RAB9A 2000/4885RAF1 2/4885
US-20130158076-A1 Methylene Urea Derivatives BRAF, RAF1, CMPK1 DDR2 4558/4885RAB9A 2000/4885RAF1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.